Literature DB >> 18766317

An accumulation of two independent selection factors decreases the success rate of female students at the MUV (Medical University of Vienna).

Lukas Mitterauer1, Gerald Haidinger, Oskar Frischenschlager.   

Abstract

Inspired by the implementation of a reformed medical curriculum at the Medical University of Vienna (Austria, MUV), we have investigated predictors for success in the decisive exam at the end of the first study-year (SIE). In four consecutive cohorts of freshmen, we have found that female students show significantly lower success rates (Odds Ratio, OR=1.67, 95%CI 1.44-1.97). By the introduction of a pre-selection of applicants ("aptitude test for medical studies", EMS) in 2006, a new and additional significant hindrance for female students emerged. Their OR for not being accepted into the second study-year increased to OR=2.14 (95%CI 1.68-2.72), compared to male students.

Mesh:

Year:  2008        PMID: 18766317     DOI: 10.1007/s10354-008-0571-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  4 in total

1.  Factors associated with academic success at Vienna Medical School: prospective survey.

Authors:  Oskar Frischenschlager; Gerald Haidinger; Lukas Mitterauer
Journal:  Croat Med J       Date:  2005-02       Impact factor: 1.351

2.  Prediction of success in the first-year exam in the study of medicine--a prospective survey.

Authors:  Gerald Haidinger; Oskar Frischenschlager; Lukas Mitterauer
Journal:  Wien Klin Wochenschr       Date:  2005-12       Impact factor: 1.704

3.  Reliability of predictors of study success in medicine.

Authors:  Gerald Haidinger; Oskar Frischenschlager; Lukas Mitterauer
Journal:  Wien Med Wochenschr       Date:  2006-07

4.  [Learning strategy or strategic learning? Gender-dependent success in medical studies at the Medical University of Vienna].

Authors:  Gerald Haidinger; Lukas Mitterauer; Evelyne Rimroth; Oskar Frischenschlager
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.